Skip to main content

Table 1 Basic clinical data of subjects in the LDL group and control group

From: Several circulating miRNAs related to hyperlipidemia and atherosclerotic cardiovascular diseases

Terms

Hyperlipidemia group (n = 122)

Normal group (n = 168)

P-value

Age (years)

50.06 ± 1.09

48.601 ± 0.84

0.407

Sex (male/female)

74/48

69/99

0.378

History of smoking (Smoker/Nonsmoker)

45/77

60/108

0.522

History of alcoholism (Yes/No) NoNONo)Nondrinker)

42/80

64/104

0.520

Body mass index (BMI)

24.56 ± 0.22

23.72 ± 0.24

0.064

Hypertension (Yes/No)

38/84

68/100

0.103

Diabetes (Yes/ No)

26/96

50/118

0.106

Carotid plaque (Yes/ No)

46/56

47/99

0.039

Not checked

20

22

 

History of stroke (Yes/ No)

25/97

22/146

0.092

History of coronary heart disease

33/89

34/134

0.174

ASCVD

53/69

41/119

0.002

Fatty liver

41/81

34/134

0.101

Random blood glucose

5.81 ± 0.27

5.33 ± 0.06

0.126

Creatinine

70.6 ± 1.36

71.78 ± 3.17

0.349

Urea nitrogen

5.33 ± 0.13

5.60 ± 0.13

0.083

Uric acid

345.68 ± 7.50

321.4 ± 6.41

0.013

AST

20.4 ± 0.78

19.9 ± 0.42

0.507

ALT

24.93 ± 1.45

21.73 ± 1.12

0.111

TC

6.34 ± 0.14

4.37 ± 0.28

0.024

TG

1.77 ± 1.07

2.01 ± 0.59

0.067

HDL-C

1.16 ± 0.53

1.58 ± 0.31

0.021